|
Drugmakers Argue Against Disclosure of Possibly Unrelated Adverse Events
Trade groups representing drugmakers and biotechnology companies have weighed in on a lawsuit involving disclosure of possibly unrelated adverse events. Read more »
|
|
DDMAC Enforcement Letters Up; Most Cite Risk Info Problems
DDMAC warnings and notices issued in the first half of this year have increased significantly in comparison to recent years and data show that risk information is one of the most common problems cited. Read more »
|
More Health & Regulatory News »